Donald Trump tariffs to dent India’s GDP growth? Up to 30 basis points dip possible, say experts; expected trade deal could soften blow

AI-generated image The imposition of a 25 per cent US tariff on Indian goods from August 1, along with an unspecified penalty over India’s continued trade with Russia, could weigh on India’s GDP growth and export prospects, experts have warned. Sectors such as pharmaceuticals, gems and jewellery, textiles, and automobiles are likely to be most…

Read More

Pradhan Mantri Kisan Sampada Yojana boost: Centre clears Rs 6,520 crore for PMKSY expansion, 50 irradiation units and 100 food labs in pipeline

The Union Cabinet has approved a total outlay of Rs 6,520 crore — including an additional Rs 1,920 crore — for the Central Sector Scheme Pradhan Mantri Kisan Sampada Yojana (PMKSY) during the ongoing 15th Finance Commission cycle (2021–22 to 2025–26), the government said in an official release said.The allocation includes Rs 1,000 crore to…

Read More

‘India set to be third largest economy’, says Piyush Goyal after Donald Trump’s ‘dead economy’ jibe; reiterates national interest important

Piyush Goyal said that India will protect its national interest while pursuing any trade deal. Commerce minister Piyush Goyal on Thursday said that India will protect its national interest while pursuing any trade deal with world economies. Goyal’s comments in the Parliament come after US announced a 25% tariff on India. In what appeared to…

Read More

Cooperative capital boost: Cabinet okays Rs 2,000cr aid to NCDC; cooperatives to gain Rs 20,000cr from market raise

The Union Cabinet approved a Central Sector Scheme for providing Rs 2,000 crore in grant-in-aid to the National Cooperative Development Corporation (NCDC) over four years, with the aim of boosting cooperative activity across key rural sectors.According to the government release, the outlay — Rs 500 crore annually from FY26 to FY29 — will enable NCDC…

Read More

Pharma downplays 25% tariff impact: US healthcare could feel the blow instead of India- what sector experts say

India’s pharmaceutical sector has given its insights into US President Donald Trump’s announcement of a 25 per cent tariff on all Indian imports starting August 1, warning that the move could significantly disrupt American healthcare rather than weaken Indian industry. While uncertainty remains about whether pharmaceuticals will fall under the new tariff list- given Trump’s…

Read More